Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica MacIntyre

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Psycho-Oncology|January 28, 2024
Associations between age and patient-reported outcomes, emergency department visits, and hospitalizations among lung cancer patients receiving immune checkpoint inhibitorsSara E Fleszar-Pavlovic, Akina Natori, Patricia I Moreno, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 4, 2024
Patterns of patient-reported outcomes (PROs) in a diverse group of gynecologic cancer survivorsCharlotte Gerrity, Abdulrahman Sinno, Akina Natori, et al.
Psychoneuroendocrinology|August 25, 2012
Incentive processing in Congenital Adrenal Hyperplasia (CAH): a reward-based antisaccade studySven C Mueller, Teresa Daniele, Jessica MacIntyre, et al.
European Journal of Pharmacology|April 23, 2014
Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculatureJessica MacIntyre, Alex Dong, Alex Straiker, et al.
American Journal of Clinical Oncology|May 10, 2011
Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancerJaime R Merchan, Annaporna Ferrell, Jessica Macintyre, et al.
Research Square|November 24, 2025
Trajectories of Patient-Reported Outcomes among Diverse Cancer Patients in Ambulatory Oncology ClinicsAkina Natori, Blanca Silvia Noriega Esquives, Vandana D Sookdeo, et al.
Journal of Gastrointestinal Oncology|March 23, 2018
The <i>nab</i>-paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinomaSofia Palacio, Peter J Hosein, Isildinha Reis, et al.
Journal of Cancer Survivorship : Research and Practice|June 4, 2026
Trajectories of patient-reported outcomes among diverse cancer patients in ambulatory oncology clinicsAkina Natori, Blanca Silvia Noriega Esquives, Vandana D Sookdeo, et al.
JCO Oncology Practice|March 15, 2022
Implementation and Feasibility of an Electronic Health Record-Integrated Patient-Reported Outcomes Symptom and Needs Monitoring Pilot in Ambulatory OncologyFrank J Penedo, Heidy N Medina, Patricia I Moreno, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2014
A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTereHeloisa P Soares, Soley Bayraktar, Marcelo Blaya, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Psycho-Oncology|January 28, 2024
Associations between age and patient-reported outcomes, emergency department visits, and hospitalizations among lung cancer patients receiving immune checkpoint inhibitorsSara E Fleszar-Pavlovic, Akina Natori, Patricia I Moreno, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 4, 2024
Patterns of patient-reported outcomes (PROs) in a diverse group of gynecologic cancer survivorsCharlotte Gerrity, Abdulrahman Sinno, Akina Natori, et al.
Psychoneuroendocrinology|August 25, 2012
Incentive processing in Congenital Adrenal Hyperplasia (CAH): a reward-based antisaccade studySven C Mueller, Teresa Daniele, Jessica MacIntyre, et al.
European Journal of Pharmacology|April 23, 2014
Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculatureJessica MacIntyre, Alex Dong, Alex Straiker, et al.
American Journal of Clinical Oncology|May 10, 2011
Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancerJaime R Merchan, Annaporna Ferrell, Jessica Macintyre, et al.
Research Square|November 24, 2025
Trajectories of Patient-Reported Outcomes among Diverse Cancer Patients in Ambulatory Oncology ClinicsAkina Natori, Blanca Silvia Noriega Esquives, Vandana D Sookdeo, et al.
Journal of Gastrointestinal Oncology|March 23, 2018
The <i>nab</i>-paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinomaSofia Palacio, Peter J Hosein, Isildinha Reis, et al.
Journal of Cancer Survivorship : Research and Practice|June 4, 2026
Trajectories of patient-reported outcomes among diverse cancer patients in ambulatory oncology clinicsAkina Natori, Blanca Silvia Noriega Esquives, Vandana D Sookdeo, et al.
JCO Oncology Practice|March 15, 2022
Implementation and Feasibility of an Electronic Health Record-Integrated Patient-Reported Outcomes Symptom and Needs Monitoring Pilot in Ambulatory OncologyFrank J Penedo, Heidy N Medina, Patricia I Moreno, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2014
A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTereHeloisa P Soares, Soley Bayraktar, Marcelo Blaya, et al.
Pageof 3